Vontobel Holding Ltd. Ptc Therapeutics, Inc. Transaction History

Vontobel Holding Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jun 03, 2024	SELL	$22.41 - $41.99 $20,662 - $38,714	-922 Reduced 3.77%	23,513 $526,000
Q3 2023 Oct 10, 2023	SELL	$22.41 - $41.99 $20,662 - $38,714	-922 Reduced 3.77%	23,513 $526,000
Q2 2023 Jun 03, 2024	BUY	$40.4 - $59.1 $987,174 - $1.44 Million	24,435 New	24,435 $993,000
Q2 2023 Jul 24, 2023	BUY	$40.4 - $59.1 $987,174 - $1.44 Million	24,435 New	24,435 $993,000
Q3 2022 Nov 04, 2022	SELL	$41.85 - $53.85 $84,788 - $109,100	-2,026 Reduced 5.41%	35,425 $1.78 Million
Q2 2022 Jul 27, 2022	BUY	$25.6 - $45.23 $147,712 - $260,977	5,770 Added 18.21%	37,451 $1.51 Million
Q1 2022 May 13, 2022	SELL	$33.33 - $44.6 $45,928 - $61,458	-1,378 Reduced 4.17%	31,681 $1.18 Million
Q4 2021 Feb 14, 2022	BUY	$35.36 - $41.86 $1.17 Million - $1.38 Million	33,059 New	33,059 $1.32 Million
Q2 2021 Aug 06, 2021	SELL	$37.95 - $49.37 $881,426 - $1.15 Million	-23,226 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$46.8 - $68.92 $5,850 - $8,615	125 Added 0.54%	23,226 $1.1 Million
Q4 2020 Feb 12, 2021	BUY	$47.96 - $67.64 $1.11 Million - $1.56 Million	23,101 New	23,101 $1.48 Million

215

79.2M

122K

212K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.69B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.